Astrana Health, Inc. $ASTH Shares Sold by Wellington Management Group LLP

Wellington Management Group LLP cut its position in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 3.7% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 1,292,573 shares of the company’s stock after selling 49,251 shares during the period. Wellington Management Group LLP’s holdings in Astrana Health were worth $59,988,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently added to or reduced their stakes in the company. Swiss National Bank increased its stake in Astrana Health by 1.2% during the third quarter. Swiss National Bank now owns 86,944 shares of the company’s stock valued at $2,465,000 after purchasing an additional 1,000 shares during the last quarter. Public Employees Retirement System of Ohio bought a new position in shares of Astrana Health in the 2nd quarter worth about $51,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Astrana Health by 5.2% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company’s stock valued at $799,000 after buying an additional 1,263 shares during the period. Deutsche Bank AG boosted its holdings in shares of Astrana Health by 3.9% in the 4th quarter. Deutsche Bank AG now owns 41,265 shares of the company’s stock valued at $1,024,000 after buying an additional 1,550 shares during the period. Finally, Price T Rowe Associates Inc. MD grew its position in shares of Astrana Health by 3.8% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 42,258 shares of the company’s stock valued at $1,049,000 after buying an additional 1,562 shares during the last quarter. Institutional investors and hedge funds own 52.77% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. TD Cowen increased their price objective on shares of Astrana Health from $45.00 to $50.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Needham & Company LLC lifted their target price on Astrana Health from $30.00 to $41.00 and gave the company a “buy” rating in a research note on Friday, May 8th. Weiss Ratings reiterated a “hold (c)” rating on shares of Astrana Health in a research report on Thursday, August 27th. Wall Street Zen downgraded Astrana Health from a “buy” rating to a “hold” rating in a report on Sunday, August 16th. Finally, Robert W. Baird set a $45.00 price objective on Astrana Health in a research report on Friday, May 8th. Seven investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $49.43.

Astrana Health Trading Down 0.1%

NASDAQ:ASTH opened at $38.57 on Thursday. The stock has a market cap of $2.15 billion, a price-to-earnings ratio of 47.04 and a beta of 0.90. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.23 and a current ratio of 1.23. Astrana Health, Inc. has a 1 year low of $18.08 and a 1 year high of $51.60. The business has a fifty day moving average of $41.19 and a 200-day moving average of $34.49.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.34 by $0.46. The business had revenue of $972.52 million for the quarter, compared to analysts’ expectations of $985.62 million. Astrana Health had a net margin of 1.05% and a return on equity of 10.30%. The company’s revenue was up 48.5% on a year-over-year basis. During the same period in the previous year, the business earned $0.19 earnings per share. Equities analysts predict that Astrana Health, Inc. will post 1.32 earnings per share for the current year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.